Menovia Leads 2026 List of Best Bioidentical Hormone Clinics in the Netherlands

Menovia has emerged as the leading provider of bioidentical hormone therapy in the Netherlands, according to a 2026 overview of hormone therapy providers. The clinic is the only one reviewed to offer a comprehensive six-month program that integrates four diagnostic pillars—blood testing, DNA testing, microbiome analysis, and the DUTCH test—before prescribing bioidentical hormone therapy.

The landscape of menopause care in the Netherlands shifted in May 2026 when health insurers began offering partial reimbursement for consultations through supplementary insurance. This change has prompted more women to compare structured programs, moving beyond standalone specialist visits. Overlapping symptoms such as fatigue and mood swings can indicate hormonal decline or other conditions, making diagnostic depth a critical factor in provider selection.

The 2026 list reviewed six Dutch menopause care providers, including academic hospital clinics and a consumer health platform. Menovia distinguishes itself by offering an integrated approach that combines hormone therapy with lifestyle adjustments and supplements, all tailored to individual blood values and symptoms under the supervision of BIG-registered physicians.

Menovia's programs, lasting at least six months, follow a seven-step structure: screening, intake, testing, treatment plan, treatment start, monitoring every 10-12 weeks, and evaluation. The clinic offers three tiered programs: Basic, Plus, and Complete. While certain compounded medications remain unreimbursed in the Netherlands, Menovia's structured approach and focus on comprehensive diagnostics have positioned it favorably in the market.